Body Weight Support Gait Training
DeviceOther names: BSWTT, LiteGait
NCT Number: NCT03602313
Randomized trial of patients with cerebrovascular accident (CVA) receiving traditional and body weight supported (BWS) gait training. Participants are enrolled and randomized upon entry into acute care and gait is evaluated within 48 hours of discharge from the rehabilitation hospital. Gait analysis is used to determine which of the two groups achieved gait parameters most similar to the normal gait of an age-matched population.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Potential participants are identified upon admission to acute care post cerebrovascular accident (CVA) and screened for inclusion. Informed consent is obtained from the patient and/or designee. Demographic information is obtained from the medical record, the patient and/or designee by the clinical coordinator. The participant is randomized into traditional gait training group or body weight support (BWS) group. The participant receives the required amount of physical therapy as directed by clinicians at the acute care facility and accrediting agencies.
The traditional gait training group will receive gait training as presently performed without additional modalities. The BWS group will received BWS gait training in lieu of traditional gait training. Participants will be treated in in-patient rehabilitation for a duration as determined by the clinical team; thus, the overall duration of care may be variable between participants. Time spent in gait training activities for both groups will be tracked by both service unit and by time (minutes).
Within 48 hours of discharge from the acute care facility, the participant will be transported to a separate site for kinematic gait analysis using a marker based motion capture system.
The procedure for gait analysis is as follows:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: BSWTT, LiteGait
Other names: Overground
Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.
Velocity of center of mass of the participant.
Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.
Difference in position between the feet at heel strike, in the direction of forward motion.
Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.
Difference in position between the feet at heel strike, in the direction normal to the direction of forward motion.
Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.
The ratio of the difference of left and right step length over the stride length.
Time frame: Measured at discharge, approximately 21 days
Measure of the quantity of therapy received during the duration of care.
Time frame: Admission of the FIM is completed within 72 hours of the start of a rehabilitation, and within 75 hours of discharge, approximately 21 days
A 17 items survey of patient independence in 2 domains, motor and cognition. It is used as a basic indicator of patient disability.
Time frame: Approximately 21 days. Determined by the study clinicians based on severity of disability and rate of progress.
Total duration of care at the acute rehabilitation facility.
Florida Gulf Coast University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05823298
Brain Diseases, CVA (Cerebrovascular Accident)
Istanbul, Esenyurt, Turkey (Türkiye)
View Trial DetailsNCT07435688
Brain Diseases, CVA (Cerebrovascular Accident)
Istanbul, Büyükcekmece, Turkey (Türkiye)
View Trial DetailsNCT07425158
Brain Diseases, CVA (Cerebrovascular Accident)
Raanana, Israel
View Trial DetailsNCT05311384
Brain Diseases, CVA (Cerebrovascular Accident)
Birmingham, Alabama, United States
View Trial Details